Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

388.37
BATS BZX Real-Time Price
As of 12:08pm ET
 -2.97 / -0.76%
Today’s Change
329.09
Today|||52-Week Range
605.93
-28.46%
Year-to-Date
Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
Jul 22 / TheStreet.com - Paid Partner Content
Here's Why Regeneron Pharmaceuticals, Inc. Dropped Another 12% in June
Jul 13 / MotleyFool.com - Paid Partner Content
Why I Bought Shares of Regeneron Pharmaceuticals Inc. Last Week
Jul 20 / MotleyFool.com - Paid Partner Content
Amgen's Repatha Gains FDA Approval for New Dosing Option
Jul 12 / Zacks.com - Paid Partner Content
3 Biotech Stocks to Buy and Hold
Jul 19 / MotleyFool.com - Paid Partner Content
Instant Analysis: Amgen's Latest Approval Raises the Bar Yet Again on Regeneron Pharm...
Jul 12 / MotleyFool.com - Paid Partner Content
3 Stocks Driving The Health Care Sector Higher
Jul 18 / TheStreet.com - Paid Partner Content
Wall Street set for best week since late 2014 as stocks rebound
Jul 01 / FT.com - Paid Partner Content
Pfizer Publishes Final Data from Atopic Dermatitis Studies
Jul 14 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close391.34
Today’s open392.67
Day’s range387.86 - 392.67
Volume3,638
Average volume (3 months)930,466
Market cap$41.1B
Dividend yield--
Data as of 12:08pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-9.59%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+45.55%
P/E ratio61.5
Price/Sales15.24
Price/Book11.21

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+0.30+0.24%
ZTSZoetis Inc-0.42-0.84%
SHPGShire-2.51-1.30%
MYLMylan NV+0.31+0.67%
Data as of 12:12pm ET, 07/25/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$2.65
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

Partner Offers

Search for Jobs